Nobuyuki Kurosawa

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 3

Top Topics

Regulatory T Cells

Respiratory Syndrome Coronavirus

Photodynamic Therapy

Monoclonal Antibody

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Tatsuhiko Ozawa, Hideki Tani, Yuki Anraku, Shunsuke Kita, Emiko Igarashi, Yumiko Saga, Noriko Inasaki, Hitoshi Kawasuji, Hiroshi Yamada, So-Ichiro Sasaki, Mayu Somekawa, Jiei Sasaki, Yoshihiro Hayakawa, Yoshihiro Yamamoto, Yoshitomo Morinaga, Nobuyuki Kurosawa, Masaharu Isobe, Hideo Fukuhara, Katsumi Maenaka, Takao Hashiguchi, Hiroyuki Kishi, Isao Kitajima, Shigeru Saito, Hideki Niimi
Novel super-neutralizing antibody UT28K is capable of protecting against infection from a wide variety of SARS-CoV-2 variants. mAbs 14 (1) (2022)
Nobuyuki Kurosawa, Aki Midorikawa, Kenta Ida, Yuka Wakata Fudaba, Masaharu Isobe
Development of a T-cell receptor mimic antibody targeting a novel Wilms tumor 1-derived peptide and analysis of its specificity. Cancer science 111 (10) (2020)
Shun Matsuzawa, Yuka Wakata, Fumiya Ebi, Masaharu Isobe, Nobuyuki Kurosawa
Development and validation of monoclonal antibodies against N6-methyladenosine for the detection of RNA modifications. PloS one 14 (10) (2019)